IPCRG Advocacy

Our vision: Breathing and feeling well through universal access to right care

That is, we advocate for a priority to respiratory health, as indicated by the latest Global Burden of Disease figures in all ages and all resource settings (breathing and feeling well); we advocate for the importance of primary care globally to improve access to care (universal access) and advocate for investment in primary care to have the capability to deliver good respiratory outcomes (right care).

We call on governments & payors

To build trust in primary care and to invest in:

  1. Primary care to prevent, diagnose and treat respiratory disease & tobacco dependence applying right care
  2. Practical peer-led training and education
  3. Integrated care systems, involving patients, primary and secondary, multi-disciplinary health and social care
  4. Generation of real life evidence to feed guidelines that are useful in primary care
  5. Primary care as population health educators
  6. Right incentives to practise population respiratory heath: go where the people in need are
  7. Universal access to good quality inhaled medicines and devices and tobacco treatment and training in how to use them
  8. IPCRG that can leverage major clinician-led change working locally, collaborating globally

The role of primary care

Download our presentation on the role of primary care in the diagnosis and management of asthma and COPD at the WHO-GARD Beijing world meeting 2019 

IPCRG represents primary care in the WHO-GARD Planning Groups 

We regularly showcase the value of primary care in our publications and in programmes such as Asthma Right Care and COPD Right Care.

Importance of respiratory health

In addition, we collaborate with patient organisations, EFA and ELF, World Health Organization and other partners to explain the importance of respiratory health, how to protect it and reduce the impact of respiratory ill-health.   Our FRESH AIR and Global Bridges programmes included large-scale public education programmes on the risk of tobacco smoking and indoor air pollution to health.  

We work with organisations like EFA on European consultations on environmental issues to ensure people with respiratory problems maintain access to the best medicines for them, at the lowest carbon footprint eg  F-gas regulation.

Our members work locally to raise public awareness and often collaborate on awareness days such as World Asthma Day and World COPD Day and World Lung Day.


Investment in respiratory research

Working with the Global Health Respiratory Network we advocate for more investment in respiratory research to rebalance the inequitable distribution of funds for non-communicable and communicable diseases.